University of Pittsburgh Medical Center (UPMC)
https://www.upmc.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From University of Pittsburgh Medical Center (UPMC)
ESMO: Cardiff Oncology Falls Despite Onvansertib’s Broad Potential In KRAS-Mutant CRC
A planned Phase II trial for PLK1 inhibitor onvansertib in KRAS-mutant colorectal cancer may support accelerated approval, but results are two years off and the company cut its prostate cancer plans to conserve cash.
Company Information
- Industry
- Academic and Research Institutions
- Other Names / Subsidiaries
-
- University of Pittsburgh Medical Center (UPMC) Enterprises
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice